1.
Skinmed
; 21(2): 110-111, 2023.
Article
in English
| MEDLINE
| ID: mdl-37158351
ABSTRACT
EpsolayTM cream is a novel topical treatment that utilizes microencapsulated benzoyl peroxide to treat moderate to severe papulopustular rosacea. It is effective at decreasing, and for some patients clearing, the papules, pustules, and telangiectasias associated with rosacea. It is well-tolerated with minimal adverse effects and has demonstrated efficacy comparable to other topical agents that are used for the condition.
Subject(s)
Dermatologic Agents , Rosacea , Humans , Metronidazole , Rosacea/drug therapy , Benzoyl Peroxide/therapeutic use , Administration, Topical , Emollients/therapeutic use , Treatment Outcome
2.
Skinmed
; 17(3): 181-183, 2019.
Article
in English
| MEDLINE
| ID: mdl-31496472
Subject(s)
Adrenal Cortex Hormones/administration & dosage , Clobetasol/analogs & derivatives , Nicotinic Acids/administration & dosage , Psoriasis/drug therapy , Retinoids/administration & dosage , Administration, Topical , Adult , Clobetasol/administration & dosage , Drug Combinations , Humans , Randomized Controlled Trials as Topic , Skin Cream , Treatment Outcome
3.
Skinmed
; 17(2): 107-109, 2019.
Article
in English
| MEDLINE
| ID: mdl-31145061
Subject(s)
Antibodies, Monoclonal, Humanized/therapeutic use , Dermatitis, Atopic/drug therapy , Dermatologic Agents/therapeutic use , Adolescent , Antibodies, Monoclonal, Humanized/adverse effects , Child , Child, Preschool , Dermatologic Agents/adverse effects , Humans , Infant , Interleukin-4 Receptor alpha Subunit/antagonists & inhibitors
4.
Skinmed
; 16(5): 321-324, 2018.
Article
in English
| MEDLINE
| ID: mdl-30413226
5.
Skinmed
; 16(3): 183-187, 2018.
Article
in English
| MEDLINE
| ID: mdl-29989538
6.
Skinmed
; 15(4): 281-285, 2017.
Article
in English
| MEDLINE
| ID: mdl-28859739
Subject(s)
Antibodies, Monoclonal/therapeutic use , Dermatologic Agents/therapeutic use , Psoriasis/drug therapy , Antibodies, Monoclonal/pharmacology , Antibodies, Monoclonal, Humanized , Clinical Trials, Phase I as Topic , Clinical Trials, Phase II as Topic , Clinical Trials, Phase III as Topic , Dermatologic Agents/pharmacology , Humans
7.
Skinmed
; 12(1): 41-3, 2014.
Article
in English
| MEDLINE
| ID: mdl-24720083
Subject(s)
Dermatologic Agents/therapeutic use , Quinoxalines/therapeutic use , Rosacea/drug therapy , Administration, Cutaneous , Adrenergic alpha-2 Receptor Agonists/administration & dosage , Adrenergic alpha-2 Receptor Agonists/therapeutic use , Brimonidine Tartrate , Clinical Trials as Topic , Dermatologic Agents/administration & dosage , Dermatologic Agents/adverse effects , Gels , Humans , Quinoxalines/administration & dosage , Quinoxalines/adverse effects , Rosacea/pathology
8.
Skinmed
; 11(2): 111-5, 2013.
Article
in English
| MEDLINE
| ID: mdl-23745230
